Clinical Trial Update: Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 SRD/MRD study of BI 671800 in healthy Asian volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Perennial
• Asthma

Drugs mentioned

• BI 671800

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma, Rhinitis, Allergic, Perennial | Phase 1 | Status: COMPLETED